Emerging Pathogens in Transfusion Medicine

Clinics in Laboratory Medicine

Volumn 30, Issue 2, 2010, Pages 499-509

  Dodd, Roger Y ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

Blood safety; Blood transfusion; Emerging infections; Infectious disease

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARBOVIRUS; BABESIOSIS; BLOOD DONOR; BLOOD TRANSFUSION; CHAGAS DISEASE; DENGUE; DISEASE TRANSMISSION; EPIDEMIC; FOOD AND DRUG ADMINISTRATION; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INFECTION RISK; NONHUMAN; PATIENT SAFETY; PREVALENCE; PRIORITY JOURNAL; RETROVIRUS; REVIEW; RISK REDUCTION; THROMBOCYTE TRANSFUSION; VARIANT CREUTZFELDT JAKOB DISEASE; WEST NILE FEVER;

BLOOD DONORS; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; COMMUNICABLE DISEASES, EMERGING; HUMANS;

EID: 77953332810     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2010.02.007     Document Type: Review

References (52)

1. Weiss R.A., McMichael A.J. Social and environmental risk factors in the emergence of infectious diseases. Nat Med 2004, 10:S70-S76.
2. Wolfe N.D., Dunavan C.P., Diamond J. Origins of major human infectious diseases. Nature 2007, 447:279-283.
3. Guan Y., Zheng B.J., He Y.Q., et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 2003, 302:276-278.
4. Vijayanand P., Wilkins E., Woodhead M. Severe acute respiratory syndrome (SARS): a review. Clin Med 2004, 4:152-160.
5. Stramer S.L., Hollinger F.B., Katz L.M., et al. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion 2009, 49(Suppl 2):1S-29S.
6. Peterman T.A., Jaffe H.W., Feorino P.M., et al. Transfusion-associated acquired immunodeficiency syndrome in the United States. JAMA 1985, 254:2913-2917.
7. Barre-Sinoussi F., Chermann J.-C., Rey F., et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983, 220:868-871.
8. Gallo R.C., Salahuddin S.Z., Popovic M., et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984, 224:500-503.
9. Peterman T.A., Lui K.-J., Lawrence D.N., et al. Estimating the risks of transfusion-associated acquired immune deficiency syndrome and human immunodeficiency virus infection. Transfusion 1987, 27:371-374.
10. Busch M.P., Young M.J., Samson S.M., et al. Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV-1 antibody screening. Transfusion 1991, 31:4-11.
11. Schorr J.B., Berkowitz A., Cumming P.D., et al. Prevalence of HTLV-III antibodies in American blood donors. N Engl J Med 1985, 313:384-385.
12. Apetrei C., Loussert-Ajaka I., Descamps D., et al. Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions. AIDS 1996, 10:F57-F60.
13. Schable C., Zekeng L., Pau C.-P., et al. Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet 1994, 344:1333-1334.
14. Hewitt P.E., Llewelyn C.A., Mackenzie J., et al. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang 2006, 91:221-230.
15. Zou S., Fang C.T., Schonberger L.B. Transfusion transmission of human prion diseases. Transfus Med Rev 2008, 22:58-69.
16. Houston F., McCutcheon S., Goldmann W., et al. Prion diseases are efficiently transmitted by blood transfusion in sheep. Blood 2008, 112:4739-4745.
17. Sowemimo-Coker S.O., Pesci S., Andrade F., et al. Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates. Vox Sang 2006, 90:265-275.
18. Gregori L., Gurgel P.V., Lathrop J.T., et al. Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins. Lancet 2006, 368:2226-2230.
19. Petersen L.R., Hayes E.B. Westward ho?-The spread of West Nile virus. N Engl J Med 2004, 351:2257-2259.
20. Biggerstaff B.J., Petersen L.R. Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion 2002, 42:1019-1026.
21. Pealer L.N., Marfin A.A., Petersen L.R., et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003, 349:1236-1245.
22. Dodd R.Y. Emerging infections, transfusion safety, and epidemiology. N Engl J Med 2003, 349:1205-1206.
23. Schmuñis G.A. Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countries. Transfusion 1991, 31:547-557.
24. Schmunis G.A., Cruz J.R. Safety of the blood supply in Latin America. Clin Microbiol Rev 2005, 18:12-29.
25. Leiby D.A., Read E.J., Lenes B.A., et al. Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donors. J Infect Dis 1997, 176:1047-1052.
26. Bern C., Montgomery S.P., Katz L., et al. Chagas disease and the US blood supply. Curr Opin Infect Dis 2008, 21:476-482.
27. Leiby D.A. Babesiosis and blood transfusion: flying under the radar. Vox Sang 2006, 90:157-165.
28. Gubernot D.M., Lucey C.T., Lee K.C., et al. Babesia infection through blood transfusions: reports received by the US Food and Drug Administration, 1997-2007. Clin Infect Dis 2009, 48:25-30.
29. Tonnetti L., Eder A.F., Dy B., et al. Transfusion-transmitted Babesia microti identified through hemovigilance. Transfusion 2009, 49:2557-2563.
30. Chuang V.W., Wong T.Y., Leung Y.H., et al. Review of dengue fever cases in Hong Kong during 1998 to 2005. Hong Kong Med J 2008, 14:170-177.
31. Tambyah P.A., Koay E.S., Poon M.L., et al. Dengue hemorrhagic fever transmitted by blood transfusion. N Engl J Med 2008, 359:1526-1527.
32. Linnen J.M., Vinelli E., Sabino E.C., et al. Dengue viremia in blood donors from Honduras, Brazil, and Australia. Transfusion 2008, 48:1355-1362.
33. Mohammed H., Linnen J.M., Munoz-Jordan J.L., et al. Dengue virus in blood donations, Puerto Rico, 2005. Transfusion 2008, 48:1348-1354.
34. Kumarasamy V., Wahab A.H., Chua S.K., et al. Evaluation of a commercial dengue NS1 antigen-capture ELISA for laboratory diagnosis of acute dengue virus infection. J Virol Methods 2007, 140:75-79.
35. Charrel R.N., de L X., Raoult D. Chikungunya outbreaks-the globalization of vectorborne diseases. N Engl J Med 2007, 356:769-771.
36. Tsetsarkin K.A., Vanlandingham D.L., McGee C.E., et al. A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog 2007, 3:e201.
37. Brouard C., Bernillon P., Quatresous I., et al. Estimated risk of Chikungunya viremic blood donation during an epidemic on Reunion Island in the Indian Ocean, 2005 to 2007. Transfusion 2008, 48:1333-1341.
38. Rezza G., Nicoletti L., Angelini R., et al. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 2007, 370:1840-1846.
39. Lanciotti R.S., Kosoy O.L., Laven J.J., et al. Chikungunya virus in US travelers returning from India, 2006. Emerg Infect Dis 2007, 13:764-767.
40. Dorsey K., Zou S., Schonberger L.B., et al. Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study. Transfusion 2009, 49:977-984.
41. Belay E.D., Maddox R.A., Williams E.S., et al. Chronic wasting disease and potential transmission to humans. Emerg Infect Dis 2004, 10:977-984.
42. Belay E.D., Gambetti P., Schonberger L.B., et al. Creutzfeldt-Jakob disease in unusually young patients who consumed venison. Arch Neurol 2001, 58:1673-1678.
43. Jones-Engel L., Engel G.A., Schillaci M.A., et al. Primate-to-human retroviral transmission in Asia. Emerg Infect Dis 2005, 11:1028-1035.
44. Switzer W.M., Bhullar V., Shanmugam V., et al. Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates. J Virol 2004, 78:2780-2789.
45. Brooks J.I., Merks H.W., Fournier J., et al. Characterization of blood-borne transmission of simian foamy virus. Transfusion 2007, 47:162-170.
46. Khan A.S., Kumar D. Simian foamy virus infection by whole-blood transfer in rhesus macaques: potential for transfusion transmission in humans. Transfusion 2006, 46:1352-1359.
47. Boneva R.S., Grindon A.J., Orton S.L., et al. Simian foamy virus infection in a blood donor. Transfusion 2002, 42:886-891.
48. Winkler I.G., Flügel R.M., Asikainen K., et al. Antibody to human foamy virus not detected in individuals treated with blood products or in blood donors. Vox Sang 2000, 79:118-119.
49. O'Brien S.F., Yi Q.L., Fearon M.A., et al. A predonation screening question for occupational exposure to simian foamy virus: a preliminary donor survey in Canada. Transfusion 2007, 47:949-950.
50. Lombardi V.C., Ruscetti F.W., Das G.J., et al. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 2009, 326:585-589.
51. Prowse C., Robinson A.E. Pathogen inactivation of labile blood components. Transfus Med 2001, 11:147.
52. Webert K.E., Cserti C.M., Hannon J., et al. Proceedings of a Consensus Conference: pathogen inactivation-making decisions about new technologies. Transfus Med Rev 2008, 22:1-34.